NEJM -- Effect of Nateglinide on the Incidence of Diabetes and Cardiovascular Events
Links shared publicly online about this topic.
- 1,314total visits
NEJM -- Effect of Nateglinide on the Incidence of Diabetes and Cardiovascular Events
View full resource at content.nejm.org
Tags: Diabetes
Most Recently Shared on March 15, 2010 at 1:24 am By:
Meglitinides - did not decrease the risk of developing DM2 in pats with glucose intolerance - http://bit.ly/bvfjgE
Nursing Medical News about Diabetes Mellitus Cardiovascular Diseases
mdlinx.com — “Effect of Nateglinide on the Incidence of Diabetes and Cardiovascular Events” View full resource at mdlinx.com
Most Recently Shared on April 22, 2010 at 10:51 pm By:
Sandeep Pulim MD Doctor, Health Communicator, and Physician
Effect of Nateglinide on the Incidence of Diabetes and Cardiovascular Events: New England Journal of Medicine http://bit.ly/9xZlhV #Nursing
Cardiology Medical News about Diabetes Mellitus Cardiovascular Diseases
mdlinx.com — “Effect of Nateglinide on the Incidence of Diabetes and Cardiovascular Events” View full resource at mdlinx.com
Most Recently Shared on April 22, 2010 at 9:24 am By:
Sandeep Pulim MD Doctor, Health Communicator, and Physician
Effect of Nateglinide on the Incidence of Diabetes and Cardiovascular Events: New England Journal o... http://bit.ly/cmHyMx #cardio #mdlinx
NEJM -- Effect of Valsartan on the Incidence of Diabetes and Cardiovascular Events
content.nejm.org — “Original Article from The New England Journal of Medicine -- Effect of Valsartan on the Incidence of Diabetes and Cardiovascular Events” View full resource at content.nejm.org
Most Recently Shared on March 15, 2010 at 1:22 am By:
M Auron MD Doctor, Pediatrician, Internist, and Physician
Valsartan decreases by 14% the risk of progression to DM2 in pats with glucose intolerance - http://bit.ly/btF4Ns
Advertisement
